
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight Inc. is positioned for sustained double-digit growth, primarily driven by increasing utilization rates and the expansion of its light adjustable lens (LDD) installed base. Key potential upside factors include faster-than-anticipated growth in the LDD installed base, improved lens volume sales, and enhanced profit margins. Additionally, the company is expected to experience improved cash burn as light adjustable lenses comprise a larger portion of total revenue.
Bears say
RxSight faces significant challenges that contribute to a negative outlook on its stock. The company is experiencing limited adoption of its products, primarily due to the requirement for an incremental capital equipment investment, coupled with disappointing commercial execution and increasing competition in the intraocular lens (IOL) market. Additionally, financial projections have been revised downward, with expected revenues for 2025 and 2026 reduced to $164 million and $205 million, respectively, indicating a concerning trend in anticipated growth.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares